EyePoint Pharmaceuticals
EYPT
EYPT
30 hedge funds and large institutions have $24.4M invested in EyePoint Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Holders
30
Holding in Top 10
–
Calls
$2.21M
Puts
$1.19M
Top Buyers
| 1 | +$4.71M | |
| 2 | +$1.99M | |
| 3 | +$1.04M | |
| 4 |
Jane Street
New York
|
+$544K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$483K |
Top Sellers
| 1 | -$3.17M | |
| 2 | -$1.15M | |
| 3 | -$733K | |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$407K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$299K |